Cargando…
The pseudoginsenoside F11 ameliorates cisplatin-induced nephrotoxicity without compromising its anti-tumor activity in vivo
The clinical use of cisplatin was severely limited by its associated nephrotoxicity. In this study, we investigated whether the pseudoginsenoside F11 had protective effects against cisplatin-induced nephrotoxicity. To clarify it, one in vivo model of cisplatin-induced acute renal failure was perform...
Autores principales: | Wang, Hongbo, Kong, Liang, Zhang, Jianqiao, Yu, Guohua, Lv, Guangyao, Zhang, Fangxi, Chen, Xiaoguang, Tian, Jingwei, Fu, Fenghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023132/ https://www.ncbi.nlm.nih.gov/pubmed/24832194 http://dx.doi.org/10.1038/srep04986 |
Ejemplares similares
-
Terahertz Spectroscopy for Accurate Identification of Panax quinquefolium Basing on Nonconjugated 24(R)-Pseudoginsenoside F(11)
por: Kou, Tianyi, et al.
Publicado: (2021) -
Neuroprotective Effect of Pseudoginsenoside-F11 on a Rat Model of Parkinson's Disease Induced by 6-Hydroxydopamine
por: Wang, Jian Yu, et al.
Publicado: (2013) -
Amelioration of cisplatin-induced nephrotoxicity by statins
por: Maheshwari, Rajesh A., et al.
Publicado: (2013) -
PM315. Pseudoginsenoside-F11 inhibits methamphetamine dependence by regulating GABAergic and opioidergic neuronal system in the nucleus accumbens of mice
por: Fu, Kequan, et al.
Publicado: (2016) -
Pseudoginsenoside F11, a Novel Partial PPARγ Agonist, Promotes Adiponectin Oligomerization and Secretion in 3T3-L1 Adipocytes
por: Wu, Guoyu, et al.
Publicado: (2013)